Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Awasthi

Showing results (121-130 of 124) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 124 results.
Plos Pathogens|April 28, 2022
A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variantNitin Hingankar, Suprit Deshpande, Payel Das, et al.
The Lancet. Infectious Diseases|November 28, 2021
Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responsesRamachandran Thiruvengadam, Amit Awasthi, Guruprasad Medigeshi, et al.
Plos Pathogens|December 12, 2022
A broadly neutralizing monoclonal antibody overcomes the mutational landscape of emerging SARS-CoV-2 variants of concernHilal Ahmad Parray, Naveen Narayanan, Sonal Garg, et al.
Nature Reviews. Immunology|November 18, 2025
Guidelines for T cell nomenclatureDavid Masopust, Amit Awasthi, Rémy Bosselut, et al.
Pageof 13

Showing results (121-130 of 124) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 124 results.
Plos Pathogens|April 28, 2022
A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variantNitin Hingankar, Suprit Deshpande, Payel Das, et al.
The Lancet. Infectious Diseases|November 28, 2021
Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responsesRamachandran Thiruvengadam, Amit Awasthi, Guruprasad Medigeshi, et al.
Plos Pathogens|December 12, 2022
A broadly neutralizing monoclonal antibody overcomes the mutational landscape of emerging SARS-CoV-2 variants of concernHilal Ahmad Parray, Naveen Narayanan, Sonal Garg, et al.
Nature Reviews. Immunology|November 18, 2025
Guidelines for T cell nomenclatureDavid Masopust, Amit Awasthi, Rémy Bosselut, et al.
Pageof 13